Google News – Clinical Trials External News
Quality, Safety & Pharmacovigilance Articles
Google News – Clinical Trials External News
Self-medication with GLP-1 receptor agonists among Brazilian Adults: findings from a web-based survey - Nature
Google News – Healthcare Jobs External News
Healthcare staffing shortages are driving a patient care quality crisis - Axios
Industry News External News
A shortage of surgeons in Malaysia's public hospitals may further impact patients' quality of care, say experts - CNA
Google News – EMA (biotech/pharma) External News
EU regulator finds no link between GLP-1s and suicidal thoughts - Fierce Pharma
Google News – FDA (biotech/pharma) External News
Amylyx eyes FDA filing for GLP-1 blocker after late-stage win in post-bariatric hypoglycemia - BioSpace
Google News – Clinical Trials External News
Some Think GLP-1s Could Be The Next Treatments For Alzheimer’s. So Far, Drug Trial Results Are A Mixed Bag - IFLScience
Google News – Clinical Trials External News
Amylyx Stock Surges 55% After GLP-1 Blocker Hits All Trial Goals - Barron's
Google News – Clinical Trials External News
Could GLP-1s help treat opioid use disorder? Vanderbilt Health study now enrolling - Vanderbilt Health News
Google News – Pharmaceuticals External News
Amylyx GLP-1 inhibitor halves blood sugar crashes in ph. 3 win - Fierce Biotech
Google News – Biopharma External News
Amylyx’s bet on a GLP-1 blocker pays off - BioPharma Dive
Industry News External News
Starbucks and Bank of America: two different paths on GLP-1 coverage
Industry News External News
Emory Healthcare and Emory Decatur Hospital earn Georgia Hospital Association statewide patient safety awards - Emory News
Google News – Pharmaceuticals External News
Amphastar Pharmaceuticals (NASDAQ:AMPH) Stands Out as a Quality Investing Candidate - ChartMill
Industry News External News